Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
ISSN: 2155-9570
Department of Ophthalmology, Jagannath Gupta Institute of Medical Sciences and Hospital, West Bengal, India
Research Article
A Prospective Study on Clinical Efficacy of Intravitreal Bevacizumab and Macular Grid Laser in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion
Author(s): Soumyadeep Hazra* and Tapes Kanti Saha
Background: Branch Retinal Vein Occlusion (BRVO) is the second most common cause of retinal vascular abnormality after
diabetic retinopathy. Persistent macular edema develops in 60% of eyes with BRVO. Untreated, only 14% of eyes with chronic
macular edema will have a Visual Acuity (VA) of 20/40 or better. If not resolved spontaneously, treatment is necessary in
the form of intravitreal injection of anti-VEGF followed by Macular Grid Laser. Bevacizumab is the anti-VEGF of choice in
developing countries because of its prolonged action and cheap price, which helps in preventing neovascularization and thus
further haemorrhages. Laser helps in stopping the leakage and thus helps in treating the macular edema.
Aim: The aim of the study is to evaluate the efficacy of intravitreal bevacizumab and macular grid laser in the management of
.. View More»
DOI:
10.35248/2155-9570.22.13.914